ErbB receptor tyrosine kinase/NF- B signaling controls mammosphere formation in human breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ErbB receptor tyrosine kinase/NF- B signaling controls mammosphere formation in human breast cancer

Published:2012-04-05 Issue:17 Volume:109 Page:6584-6589
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Hinohara K.,Kobayashi S.,Kanauchi H.,Shimizu S.,Nishioka K.,Tsuji E.-i.,Tada K.-i.,Umezawa K.,Mori M.,Ogawa T.,Inoue J.-i.,Tojo A.,Gotoh N.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference40 articles.

1. Stem cells, cancer, and cancer stem cells

2. Prospective identification of tumorigenic breast cancer cells

3. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271

4. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

5. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NRG1 promotes tumorigenesis and metastasis and afatinib treatment efficiency is enhanced by NRG1 inhibition in esophageal squamous cell carcinoma;Biochemical Pharmacology;2023-12

2. The role of the oxytocin system in the resilience of patients with breast cancer;Frontiers in Oncology;2023-09-13

3. NRG1 promotes tumorigenesis and metastasis and afatinib treatment efficiency is enhanced by NRG1 inhibition in esophageal squamous cell carcinoma;2023-07-25

4. Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications;Frontiers in Cell and Developmental Biology;2023-07-10

5. FDI-6, a FOXM1 inhibitor, activates the aryl hydrocarbon receptor and suppresses tumorsphere formation;Biochemical and Biophysical Research Communications;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3